I-STARR (Infrastructure for Studying Treatment & Addiction Recovery Residences)
ENHANCING MOUD ACCESS AND OUTCOMES THROUGH LOW-BARRIER RECOVERY HOUSING
December 15, 2026: 11 am Pacific Time / 1 pm Central Time / 2 pm Eastern Time Register for this I-STARR Webinar. (will also be available on-demand)
This webinar presents findings from a study assessing the impact of low-barrier recovery home (LBRH) residence on outcomes for residents with opioid use disorder (OUD). Examining two sites at different developmental stages to identify essential program components for successful MOUD integration, this webinar will address how LBRH influences each stage of MOUD engagement.
Presenter: Justin Bell, PhD
MUTUAL-HELP GROUPS AND MEDICATIONS FOR OPIOID USE DISORDER (MOUD)
November 17, 2026 11 am Pacific Time / 1 pm Central Time / 2 pm Eastern Time Register for this I-STARR Webinar (will also be available on-demand)
Medications for opioid use disorder (MOUD) reduce opioid use and risk for opioid-related overdose. Mutual-help groups are widely accessible, community-based recovery supports. Participation in these groups improves outcomes for a range of substance use disorders, though less is known about their effectiveness for individuals with opioid use disorder, especially those taking MOUD. Addressing this gap is important because mutual-help group participation may help build on the benefits of MOUD and many people engage with both approaches. At the same time, individuals taking MOUD may be exposed to negative attitudes about the medications at mutual-help groups, most notably at the commonly-attended 12-step group Narcotics Anonymous.
This webinar outlines the history and nature of tension between community and pharmacological recovery pathways, what is known empirically about the intersection between mutual-help participation and MOUD, and potential strategies to promote synergy between the two.
Presenter: Brandon Bergman, PhD
https://istarr.arg.org Has many practical trainings for recovery residence operators and others at https://istarr.arg.org/register/ Or: Their YouTube channel
Some examples:
Medications for Opioid Use Disorder: Medication-Assisted Recovery for Beginners. (For all audiences including recovery housing stakeholders) Nov 7, 2023 Andrew Tompkins MD, MHS, UCSF. This is an excellent fast-paced course. Professor Tompkins is a leader in the field of addiction medicine.
Integrating and Supporting MOUD in Recovery Housing: Project HOMES August 20, 2024. (Could start at 10:40)
CA Bridge
Has on-demand video and online/downloadable monographs. Courses are categorized by audience (nurses, medical providers, or navigators) at:https://bridgetotreatment.org/tools/resources/
or https://cabridge.academy.reliaslearning.com/category.aspx?zcid=14057
A few examples:
Buprenorphine: What You Need to Know Short monograph; (in multiple languages), PDF, downloadable.
Medicines for Treating Opioid Use Disorder: What You Need to Know Concise chart with four options, including no medication. PDF available.
Buprenorphine Self-Start (A guide for patients starting buprenorphine outside of hospitals or clinics). Short monograph, 2025, PDF download available
Starting Buprenorphine After Finishing Withdrawal (“Patients who have not taken opioids in a while and are no longer in withdrawal can still benefit from buprenorphine”;. . .) Short monograph, October 2020, PDFavailable
Also has summarized peer reviewed articles on implementation of OUD treatment with Medication-Assisted Treatment (MAT) by Emergency Departments, paramedics, and navigators, etc.
Advancing Clinical Addiction Care: Patients have a right to MAT – Understanding fact & fiction surrounding access to SUD care. Jun 2, 2025
Dispelling MAT Myths (Navigator Focused Series September 2025)
Video: SUD Training 101 – Substance Use Disorder & Medication for Addiction Treatment for Navigators. (2021Available Until 5/12/2027
Substance Use Disorder & Medication-Assisted Treatment (Navigator Training 101 – Session 2)
etc. CA BRIDGE is also described on our ‘Allies’ page.
Providers Clinical Support System (PCSS)
https://pcssnow.org/ Funding by the American Academy of Addiction Psychiatry (AAAP) and SAMHSA. Extensive searchable collection of courses on MOUD: https://pcssnow.org/courses/ Can search by topic (e.g., Treatment – Medications), etc., By format (video, webinar, podcast, etc.), Or by target audience: (administrators, counselors, pharmacists, judges, patient/family, etc.)
Here are examples of a search of courses for all Target Audiences in all formats filtered for methadone or buprenorphine treatment for OUD: https://pcssnow.org/courses/#results
‘Course 4: Medications for Opioid Use Disorder’ CE and CME https://pcssnow.org/courses/course-4-medications-for-opioid-use-disorder/ Online text module. Target Audience: clinicians, students, etc. One of eight foundational courses in the SUD 101 Core Curriculum.
How Does Buprenorphine Work? A series of five videos of about 5 min each featuring. Dr. John Mariani in discussion with a patient.
Patient-Centered Care: Stigma and Advocacy
Module, Target Audience(s): clinicians
Opioid Use Disorder, Shared Decision-Making – Patient and Clinician Toolkits Format: Clinical Tool
Interdisciplinary Care in Opioid Treatment: The Role of Peers in Opioid Treatment — Shared Experiences, Shared Hope Webinar
Medicine for Opioid Use Disorders: Considerations for Judges and Justice Stakeholders Webinar
Medication-Assisted Treatment: The best therapy for opioid use disorder Introductory 2-minute animated video created by the Pew Charitable Trust.
Guide for Families: Medications for Opioid Use Disorder Clinical Tool
On Our Own Maryland (OOO-MD)
OOO-MD’s Anti-Stigma Project trains MOUD providers, peer recovery specialists, and others through interactive workshops and other resources. Various types of stigma are addressed, including MOUD stigma.
Their Anti-Stigma Project (ASP) workshops were validated by independent investigators from the University of Maryland, with NIH / NIDA / HEAL-funding initiative: IRIS (Innovations in Recovery through Infrastructure Support). The trainings demonstrated significant improvements after MOUD stigma trainings.
Their program ‘Refocus: Look Again‘ addresses stigma with a wider audience through unique print and digital materials on mental illness and substance use disorder stigma. Materials such as explainers and summaries of new research are searchable (e.g. with the word ‘medication’).
See their additional trainings by category, including live online trainings. OOO-MD is also summarized on our ‘Allies’ page.
ADDICTION TECHNOLOGY TRANSFER CENTER (ATTC) Network
‘Online Learning Opportunities’ has on-demand online trainings
An example: ‘Supporting Recovery with Medications for Addiction Treatment (MAT)’ (
See their ‘Training and Events Calendar for upcoming live online trainings,’ some of these are pertinent to MOUD stigma.
AMERSA (Association for Multidisciplinary Education and Research in Substance Use and Addiction)
https://amersa.org (Some information about AMERSA is on our ‘Allies’ page)
Their Resource Library lists several resources. We recommend this excellent training for peers (sixth on the list of trainings) or via direct link: Medication For Opioid Disorder (MOUD) Toolkit For Peer Recovery Specialists
Reducing Stigma Education Tools (ReSET) Dell-Medical-School
Online, from health communication researchers at U. Texas Austin. The target audience is healthcare professionals.
ReSET (on the pcssnow.org website) takes you to the ‘Costs of Care’ modules, one of which is the ReSET course: Stigma and Opioid Use Disorder (module 1 of 5)
This includes a total of two 2-min videos of people telling their own stories about being stigmatized because of OUD. (they do not discuss MOUD). Shows examples of posters and ads on anti-OUD stigma from public information campaigns in New York City, Philadelphia, (“I am living proof that bupe works”), Massachusetts (State without Stigma campaign), St. Louis (Anyone Can program), New Hampshire (Anyone Anytime campaign), and examples of signs in emergency department in California from the CA Bridge program (“Need help with pain pills or heroin?”)